William Blake Gilmore

William Blake Gilmore

Auto-generated profile, based on publicly available information

William Blake Gilmore

Division of Cardiology, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Cell Stem Cell
Verified
Journal Article
Closed access
TMTushar Menon
Tushar Menon
AFAmy L. Firth
Amy L. Firth
DSDeirdre D. Scripture-Adams
Deirdre D. Scripture-Adams
ZGZoran Galic
Zoran Galic
SQSusan J. Qualls
Susan J. Qualls
IVInder M. Verma
Inder M. Verma

21 March 2021 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
APArash Pezhouman
Arash Pezhouman
JEJames L Engel
James L Engel
NNNgoc B Nguyen
Ngoc B Nguyen
RSRhys J P Skelton
Rhys J P Skelton
WGWilliam Blake Gilmore
William Blake Gilmore
Reza ArdehaliReza Ardehali
Reza Ardehali
Aims: We prospectively isolate and characterize first and second heart field- and nodal-like cardiomyocytes using a double reporter line from human embryonic stem cells. Our double reporter line utilizes two important transcription factors in cardiac development, TBX5 and NKX2-5. TBX5 expression marks first heart field progenitors and cardiomyocytes while NKX2-5 is expressed in nearly all myocytes of the developing heart (excluding nodal cells). We address the shortcomings of prior work in the generation of heart field-specific cardiomyocytes from induced pluripotent stem cells and provide a comprehensive early developmental transcriptomic as well as electrophysiological analyses of these three populations.Methods and results: Transcriptional, immunocytochemical, and functional studies support the cellular identities of isolated populations based on the expression pattern of NKX2-5 and TBX5. Importantly, bulk and single-cell RNA sequencing analyses provide evidence of unique molecular signatures of isolated first and second heart field cardiomyocytes, as well as nodal-like cells. Extensive electrophysiological analyses reveal dominant atrial action potential phenotypes in first and second heart fields in alignment with our findings in single-cell RNA sequencing. Lastly, we identify two novel surface markers, POPDC2 and CORIN, that enable purification of cardiomyocytes and first heart field cardiomyocytes, respectively.Conclusions: We describe a high-yield approach for isolation and characterization of human embryonic stem cell-derived heart field-specific and nodal-like cardiomyocytes. Obtaining enriched populations of these different cardiomyocyte subtypes increases the resolution of gene expression profiling during early cardiogenesis, arrhythmia modelling, and drug screening. This paves the way for the development of effective stem cell therapy to treat diseases that affect specific regions of the heart- or chamber-specific congenital heart defects.

7 June 2017 in Genesis
Verified
Journal Article
Closed access
PDF file
SRSara Ranjbarvaziri
Sara Ranjbarvaziri
SPShuin Park
Shuin Park
NNNgoc B. Nguyen
Ngoc B. Nguyen
WGWilliam B. Gilmore
William B. Gilmore
PZPeng Zhao
Peng Zhao
Reza ArdehaliReza Ardehali
Reza Ardehali

1 May 2016 in Molecular Therapy
Verified
Journal Article
Open access
BTBrian Truong
Brian Truong
PLPatrick C. Lee
Patrick C. Lee
AVAgustin Vega-Crespo
Agustin Vega-Crespo
WGWilliam B. Gilmore
William B. Gilmore
KHKip Hermann
Kip Hermann
GLGerald S. Lipshutz
Gerald S. Lipshutz